LRRK2 and non-small cell lung carcinoma: Using multigene testing panels, LRRK2 demonstrated a prognostic significance in different types of cancers, including oral squamous cell carcinomas [40], intrahepatic cholangiocarcinoma [33], non-small-cell lung cancer [41,42], and colon cancer [43].